Breaking News
February 18, 2019 - New dental adhesive prevents tooth decay around orthodontic brackets
February 18, 2019 - New eHealth tool shows potential to improve quality of asthma care
February 18, 2019 - New Australian initiative helps emergency clinicians to improve patient care
February 17, 2019 - Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
February 17, 2019 - Researchers identify faulty ‘brake’ that interferes with heart muscle’s ability to contract and relax
February 17, 2019 - Support from trusted adults can reduce risk of dying in suicidal teens, finds study
February 17, 2019 - Heart attack awareness improved since 2008
February 17, 2019 - Exercise gives a better brain boost to older men than women
February 17, 2019 - New research disproves previous assumptions of how looks influence personality
February 17, 2019 - Cannabis use as a teenager linked to depression later in life
February 17, 2019 - Sinks by Toilets in ICU Patient Rooms Harbor Harmful Bacteria
February 17, 2019 - Cancer cells’ plasticity makes them harder to stop
February 17, 2019 - Young cannabis users have increased risk of depression and suicidal behavior
February 17, 2019 - Tasmanian Devils Likely to Survive Cancer Scourge
February 17, 2019 - Neoadjuvant PD-1 blockade seems effective in glioblastoma
February 17, 2019 - Personal, social factors play role in enabling sustainable return to work after ill health
February 17, 2019 - Mouse studies show ‘inhibition’ theory of autism wrong
February 17, 2019 - Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins
February 17, 2019 - Use of liver grafts from older donors decreased despite better outcomes in recipients
February 17, 2019 - MUSC researchers discover new mechanism for a class of anti-cancer drugs
February 17, 2019 - HPV misconceptions are causing women to miss smear tests
February 17, 2019 - Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
February 17, 2019 - Researchers say auditory testing can identify children for autism screening
February 17, 2019 - New method analyzes how single biological cells react to stressful situations
February 17, 2019 - WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers
February 17, 2019 - ADHD diagnoses poorly documented
February 17, 2019 - Majority of gender minority youth do not identify with traditional sexual identity labels
February 17, 2019 - AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma
February 17, 2019 - Lower Birth Weight May Up Risk for Psychiatric Disorders
February 17, 2019 - Scientists identify reversible molecular defect underlying rheumatoid arthritis
February 17, 2019 - Moffitt researchers shed light on how CAR T cells function mechanistically
February 16, 2019 - Female Anatomy May Play Big Role in Sperm’s Success
February 16, 2019 - BMI may mediate inverse link between fiber intake, knee OA
February 16, 2019 - Movement impairments in autism can be reversed through behavioral training
February 16, 2019 - Studies address racial disparities in postpartum period and cardiovascular health
February 16, 2019 - Scientists implicate hidden genes in the severity of autism symptoms
February 16, 2019 - Decreased deep sleep linked to early signs of Alzheimer’s disease
February 16, 2019 - Neuroscientists show how the brain responds to texture
February 16, 2019 - Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
February 16, 2019 - What Can I Do About Sweating? (for Teens)
February 16, 2019 - Companies navigate dementia conversations with older workers
February 16, 2019 - Newly developed stem cell technologies show promise for treating PD patients
February 16, 2019 - Collaborative material research could advance self-assembling nanomaterials
February 16, 2019 - Researchers take major step in creating technology that mimics the human brain
February 16, 2019 - Erasing memories associated with cocaine use reduces drug seeking behavior
February 16, 2019 - Artificial intelligence can accurately predict prognosis of ovarian cancer patients
February 16, 2019 - Racial disparities in cancer deaths on the decline for America
February 16, 2019 - FDA authorizes new interoperable insulin pump for children, adults with diabetes
February 16, 2019 - Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
February 16, 2019 - Skin Cancer Screening: MedlinePlus Lab Test Information
February 16, 2019 - ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
February 16, 2019 - Cell manipulation could soon halt or reverse aging
February 16, 2019 - Pumped Breast Milk Falls Short of Breastfed Version
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - Children with ASD more likely to face maltreatment, study finds
February 16, 2019 - Study finds genetic vulnerability to use of menthol cigarettes
February 16, 2019 - Promising drug developed to rejuvenate muscle cells
February 16, 2019 - H-RT should be the standard of care for men with low risk prostate cancer, study shows
February 16, 2019 - New technique using patients’ own modified cells could help treat Crohn’s disease
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Blood clot discovery could lead to development of better treatments for blood diseases
February 16, 2019 - Intervention can increase exclusive breastfeeding rates
February 16, 2019 - New project explores how gaming technologies can help cancer patients communicate better
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
The Microbiome and Cirrhosis-Associated Hospitalization

The Microbiome and Cirrhosis-Associated Hospitalization

image_pdfDownload PDFimage_print

An interview with Dr. Jasmohan Bajaj, MBBS, MD, MS, conducted by Kate Anderton, BSc

What is the microbiome?

The microbiome refers to the collection of microorganisms that colonize the human body and includes bacteria, viruses and fungi. These microorganisms tend to inhabit specific sites in the body called physiological niches, where conditions are suitable for growth.

Credit: vrx/Shutterstock.com

For example, Staphylococcus aureus is typically found on the skin due to the slightly acidic pH of the skin and the abundance of oxygen. In the human gut, where conditions are often anaerobic, bacteria such as Lactobacilli are found.

What is the relationship between the microbiome and good health?

Focusing on the human gut, the microbiome in health is useful for several functions, including digestion of food, protecting the intestinal barrier and engaging the local immune response. This results in a metabolic factory that can communicate with the organs of the body. Bacteria in the gut can influence organs that are near, such as the liver and the bowels but also organs that are far away, such as the brain.

What are the risk factors for cirrhosis? How are these risk factors used to guide medical intervention?

The major risk factors for cirrhosis worldwide are viral hepatitis, alcohol and fatty liver disease. Often, these conditions co-exist and go relatively unnoticed by the patient, like a silent disease. The treatment of these underlying diseases could potentially prevent the development of cirrhosis and subsequent hospitalizations, but they remain undetected for many years, the cirrhosis itself may be the main driving force behind these complications.

How common is cirrhosis-associated hospitalization? What causes patients to be hospitalized with this condition?

Cirrhosis has an asymptomatic (or compensated phase) where the liver is still able to perform all of its functions, and an advanced (or decompensated phase), where complications set in. The most common cause of cirrhosis-associated hospitalizations are  complications such as fluid accumulation in the belly (ascites), confusion (hepatic encephalopathy), infections and problems with kidney function.

Patients with cirrhosis are also prone to liver cancer, which is another cause for hospitalization. Sadly, hospitalizations are distressingly common, often lead to re-hospitalizations and are very expensive regardless of the country studied.

Why is it important that new methods are developed to predict the risk of cirrhosis-associated hospitalization?

The current methods, including routine laboratory and clinical exams, have a limited predictive ability. For an outcome that is this expensive and fraught with readmissions and hospital-associated infection risks, we need to enhance these models.

We recently published a study in JCI Insight where we analyzed the microbiome of a large cohort of patients with cirrhosis. We carried out DNA and RNA analysis of stool samples provided by patients, and used this to build up a picture of the microorganisms present in their gut.

The DNA allowed us to determine the presence of live or dead bacteria, whereas the RNA demonstrated the presence of live and metabolically active bacteria. We studied the patients before and after therapies, based on whether they were on antibiotics and whether they had kidney problems or not. All patients were followed over 90 days to determine hospitalizations.

When we compared the usual clinical care models to predict hospitalizations to models that included either the DNA or RNA results, the microbiome-containing models were superior in predicting hospitalizations over and above the clinical models alone.

Importantly, the DNA+Clinical model was equivalent to the RNA+Clinical model in the prediction of hospitalization. We therefore concluded that microbiome analysis adds significantly to our current clinical models in predicting the risk of cirrhosis-associated hospitalizations.

Do you think that microbiome analysis will be routinely used in healthcare to assess the risk of cirrhosis-associated hospitalization?

It is early days yet but certainly could be an option in the future.

Credit: Anatomy Insider/Shutterstock.com

Do you think that microbiome analysis could be used to predict the risk of hospitalization for other chronic conditions?

Cirrhosis is associated with a clear disturbance of the gut microbes, which is related to the liver’s proximity and integration with the gut. This certainly should be used to predict outcomes in other gut-based diseases.

What are the next steps for your research?

We have completed a multi-center analysis of outcomes during hospitalizations for patients with cirrhosis and are currently carrying out trials related to fecal microbial transplantation.

About Dr. Jasmohan Bajaj

Dr. Jasmohan Bajaj is a Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at Virginia Commonwealth University and McGuire VA Medical Center, USA. His research focusses on hepatic encephalopathy, chronic liver disease and the microbiome, areas in which he has been principal investigator or co-investigator of many clinical trials.

Dr. Bajaj is the Chairperson for the North American Consortium for Study of End-stage Liver Disease and is the current President of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism.

He is also an Associate Editor for the American Journal of Gastroenterology and is on the editorial board for Journal of Hepatology, Hepatology, and Liver Transplantation.

 

Tagged with:

About author

Related Articles